The days when the pharmaceutical industry could relatively easily convince physicians to embrace new innovations without external input may be over. Focusing your commercial strategy solely on this type of prescriber may be risky in the long run. In the past, health care professionals expected drug info from a pharma company and device info from the manufacturer. 

But now, convincing a physician about information is more challenging than ever before, as seeking advice from many sources is considered best practice before making a decision.